E223 (Montelukast sodium (chewable) 4 mg (base))

Pill imprint E223 has been identified as Montelukast sodium (chewable) 4 mg (base).

Montelukast is used in the treatment of allergic rhinitis; asthma, maintenance; bronchospasm prophylaxis; asthma; copd and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 4 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Montelukast sodium (chewable)

Imprint:

E223

Strength:

4 mg (base)

Color:

Pink

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Leukotriene modifiers

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Qualitest Pharmaceuticals

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.